CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS

Lobbying client · District of Columbia · filed 2025 to 2026

Federal relations firm

$70,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (66100), not by name.

Firms hired 1

STRATEGIC MARKETING INNOVATIONS $70,000 6 filings

Reported by year 2 years

2026 $0 1 filing
2025 $70,000 5 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Defense, Dept of (DOD) 4
HOUSE OF REPRESENTATIVES 4
SENATE 4

Recent filings 6 total

1TY

STRATEGIC MARKETING INNOVATIONS

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 16, 2026

View → Q4

STRATEGIC MARKETING INNOVATIONS

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $10,000 income · posted Jan 21, 2026

View → Q3

STRATEGIC MARKETING INNOVATIONS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $20,000 income · posted Oct 20, 2025

View → Q2

STRATEGIC MARKETING INNOVATIONS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $20,000 income · posted Jul 18, 2025

View → Q1

STRATEGIC MARKETING INNOVATIONS

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $20,000 income · posted Apr 21, 2025

View → RR

STRATEGIC MARKETING INNOVATIONS

1st Quarter (Jan 1 - Mar 31) 2025 · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.